211 related articles for article (PubMed ID: 38429794)
1. The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review.
Nie Q; Li M; Huang C; Yuan Y; Liang Q; Ma X; Qiu T; Li J
J Transl Med; 2024 Mar; 22(1):225. PubMed ID: 38429794
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Yang K; Chen J; Zhang T; Yuan X; Ge A; Wang S; Xu H; Zeng L; Ge J
Front Immunol; 2022; 13():949746. PubMed ID: 36159792
[TBL] [Abstract][Full Text] [Related]
3. Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
Blais JE; Huang X; Zhao JV
Drugs; 2023 Apr; 83(5):403-427. PubMed ID: 36941490
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
Guo XF; Wang C; Yang T; Li S; Li KL; Li D
Food Funct; 2020 Sep; 11(9):7389-7399. PubMed ID: 32966467
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD.
Hadi A; Mohammadi H; Miraghajani M; Ghaedi E
Crit Rev Food Sci Nutr; 2019; 59(15):2494-2505. PubMed ID: 29584449
[No Abstract] [Full Text] [Related]
6. The effect of a fruit-rich diet on liver biomarkers, insulin resistance, and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trial.
Alami F; Alizadeh M; Shateri K
Scand J Gastroenterol; 2022 Oct; 57(10):1238-1249. PubMed ID: 35710164
[TBL] [Abstract][Full Text] [Related]
7. The effects of vitamin D supplementation on metabolic profiles and liver function in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
Tabrizi R; Moosazadeh M; Lankarani KB; Akbari M; Heydari ST; Kolahdooz F; Samimi M; Asemi Z
Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S975-S982. PubMed ID: 28751149
[TBL] [Abstract][Full Text] [Related]
8. The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
Abolfathi M; Mohd-Yusof BN; Hanipah ZN; Mohd Redzwan S; Yusof LM; Khosroshahi MZ
Complement Ther Med; 2020 Jan; 48():102273. PubMed ID: 31987257
[TBL] [Abstract][Full Text] [Related]
9. Physical activity intervention for non-diabetic patients with non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
Wang ST; Zheng J; Peng HW; Cai XL; Pan XT; Li HQ; Hong QZ; Peng XE
BMC Gastroenterol; 2020 Mar; 20(1):66. PubMed ID: 32164541
[TBL] [Abstract][Full Text] [Related]
10. Xiaoyao Powder in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Liu N; Yang J; Ma W; Li C; An L; Zhang X; Zou Q
J Ethnopharmacol; 2022 Apr; 288():114999. PubMed ID: 35051605
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of berberine for several cardiovascular diseases: A systematic review and meta-analysis of randomized controlled trials.
Yang L; Zhu W; Zhang X; Zhou X; Wu W; Shen T
Phytomedicine; 2023 Apr; 112():154716. PubMed ID: 36805484
[TBL] [Abstract][Full Text] [Related]
12. The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
Daneshi-Maskooni M; Keshavarz SA; Mansouri S; Qorbani M; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
Trials; 2017 Jun; 18(1):260. PubMed ID: 28592311
[TBL] [Abstract][Full Text] [Related]
13. Effects of dapagliflozin in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
Sun L; Deng C; Gu Y; He Y; Yang L; Shi J
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101876. PubMed ID: 35321843
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of berberine for dyslipidaemias: A systematic review and meta-analysis of randomized clinical trials.
Ju J; Li J; Lin Q; Xu H
Phytomedicine; 2018 Nov; 50():25-34. PubMed ID: 30466986
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Berberine Alone for Several Metabolic Disorders: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Ye Y; Liu X; Wu N; Han Y; Wang J; Yu Y; Chen Q
Front Pharmacol; 2021; 12():653887. PubMed ID: 33981233
[No Abstract] [Full Text] [Related]
16. The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
Jalali M; Mahmoodi M; Mosallanezhad Z; Jalali R; Imanieh MH; Moosavian SP
Complement Ther Med; 2020 Jan; 48():102283. PubMed ID: 31987259
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis.
Fatima K; Moeed A; Waqar E; Atif AR; Kamran A; Rizvi H; Suri NF; Haider H; Shuja SH; Khalid M; Minhas AMK
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101816. PubMed ID: 34607067
[TBL] [Abstract][Full Text] [Related]
18. Effect of exercise intervention on clinical parameters in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.
Zeng Y; Zhang X; Luo W; Sheng Y
Eur J Gastroenterol Hepatol; 2024 Jan; 36(1):1-12. PubMed ID: 37942754
[TBL] [Abstract][Full Text] [Related]
19. Positive Effects of Exercise Intervention without Weight Loss and Dietary Changes in NAFLD-Related Clinical Parameters: A Systematic Review and Meta-Analysis.
Babu AF; Csader S; Lok J; Gómez-Gallego C; Hanhineva K; El-Nezami H; Schwab U
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579012
[TBL] [Abstract][Full Text] [Related]
20. Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients.
Hu Y; Liu J; Dong X; Xu Y; Leng S; Wang G
Med Sci Monit; 2016 Nov; 22():4146-4151. PubMed ID: 27803497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
